
GoodRx Holdings Inc (NASDAQ:GDRX) is plunging Tuesday after the company reported worse-than-expected fourth-quarter financial results and issued guidance below estimates.
GoodRx said revenue increased 39% year-over-year to $213.3 million, which came in below the $217.46 million estimate. The company reported quarterly earnings of 9 cents per share, which came in below the estimate of 10 cents per share.